170 related articles for article (PubMed ID: 33048621)
1. Newly Diagnosed High-Risk Prostate Cancer in an Era of Rapidly Evolving New Imaging: How Do We Treat?
Hussain M; Lin D; Saad F; Vapiwala N; Chapin BF; Sandler H; Evans CP; Carducci MA; Sachdev S
J Clin Oncol; 2021 Jan; 39(1):13-16. PubMed ID: 33048621
[No Abstract] [Full Text] [Related]
2. Standard of Care Versus Metastases-directed Therapy for PET-detected Nodal Oligorecurrent Prostate Cancer Following Multimodality Treatment: A Multi-institutional Case-control Study.
Steuber T; Jilg C; Tennstedt P; De Bruycker A; Tilki D; Decaestecker K; Zilli T; Jereczek-Fossa BA; Wetterauer U; Grosu AL; Schultze-Seemann W; Heinzer H; Graefen M; Morlacco A; Karnes RJ; Ost P
Eur Urol Focus; 2019 Nov; 5(6):1007-1013. PubMed ID: 29530632
[TBL] [Abstract][Full Text] [Related]
3. Oligometastatic Prostate Cancer: Molecular Imaging and Clinical Management Implications in the Era of Precision Oncology.
Jadvar H
J Nucl Med; 2018 Sep; 59(9):1338-1339. PubMed ID: 30030344
[No Abstract] [Full Text] [Related]
4. From indecision to precision: advances in imaging in metastatic prostate cancer.
Bolton D; Frydenberg M
World J Urol; 2019 Jul; 37(7):1237. PubMed ID: 31139907
[No Abstract] [Full Text] [Related]
5. Prostate Specific Antigen and Prostate Specific Antigen Doubling Time Predict Findings on
Markowski MC; Sedhom R; Fu W; Gray JCR; Eisenberger MA; Pomper MG; Pienta KJ; Gorin MA; Rowe SP
J Urol; 2020 Sep; 204(3):496-502. PubMed ID: 32250727
[TBL] [Abstract][Full Text] [Related]
6. Imaging of prostate cancer.
Akin O; Hricak H
Radiol Clin North Am; 2007 Jan; 45(1):207-22. PubMed ID: 17157630
[TBL] [Abstract][Full Text] [Related]
7. Histological verification of 11C-choline-positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer.
Schilling D; Schlemmer HP; Wagner PH; Böttcher P; Merseburger AS; Aschoff P; Bares R; Pfannenberg C; Ganswindt U; Corvin S; Stenzl A
BJU Int; 2008 Aug; 102(4):446-51. PubMed ID: 18410442
[TBL] [Abstract][Full Text] [Related]
8. Prostate Cancer: Prostate-specific Membrane Antigen Positron-emission Tomography/Computed Tomography or Positron-emission Tomography/Magnetic Resonance Imaging for Staging.
Ferraro DA; Burger IA
Top Magn Reson Imaging; 2020 Feb; 29(1):59-66. PubMed ID: 32015295
[TBL] [Abstract][Full Text] [Related]
9. Detection of prostate cancer relapse with PET/CT using a novel radiotracer.
Lilleby W; Willoch F; Stensvold A
Acta Oncol; 2012 Mar; 51(3):397-9. PubMed ID: 21936756
[No Abstract] [Full Text] [Related]
10. The prostate specific antigen. Its use as a tumor marker for prostate cancer.
Kantoff PW; Talcott JA
Hematol Oncol Clin North Am; 1994 Jun; 8(3):555-72. PubMed ID: 8707772
[TBL] [Abstract][Full Text] [Related]
11. Flourodeoxyglucose positron emission tomography scan may be helpful in the case of ductal variant prostate cancer when prostate specific membrane antigen ligand positron emission tomography scan is negative.
McEwan LM; Wong D; Yaxley J
J Med Imaging Radiat Oncol; 2017 Aug; 61(4):503-505. PubMed ID: 28349676
[TBL] [Abstract][Full Text] [Related]
12. New frontiers in prostate cancer imaging: clinical utility of prostate-specific membrane antigen positron emission tomography.
Afaq A; Batura D; Bomanji J
Int Urol Nephrol; 2017 May; 49(5):803-810. PubMed ID: 28197764
[TBL] [Abstract][Full Text] [Related]
13. Re: Adverse Pathology and Undetectable Ultrasensitive Prostate-Specific Antigen after Radical Prostatectomy: Is Adjuvant Radiation Warranted?
Taneja SS
J Urol; 2015 Dec; 194(6):1631-2. PubMed ID: 26582665
[No Abstract] [Full Text] [Related]
14. [Treatment for cancer specifically diagnosed in high-aged population, prostate cancer].
Miki T
Nihon Ronen Igakkai Zasshi; 2006 Jan; 43(1):71-3. PubMed ID: 16521807
[No Abstract] [Full Text] [Related]
15. Adjuvant therapy for pathologic stage C prostate cancer: a casualty of the PSA revolution?
Anscher MS
Int J Radiat Oncol Biol Phys; 1996 Feb; 34(3):745-7. PubMed ID: 8621301
[No Abstract] [Full Text] [Related]
16.
von Eyben FE; Picchio M; von Eyben R; Rhee H; Bauman G
Eur Urol Focus; 2018 Sep; 4(5):686-693. PubMed ID: 28753806
[TBL] [Abstract][Full Text] [Related]
17. JOURNAL CLUB: Identification of Bone Metastasis With Routine Prostate MRI: A Study of Patients With Newly Diagnosed Prostate Cancer.
Woo S; Kim SY; Kim SH; Cho JY
AJR Am J Roentgenol; 2016 Jun; 206(6):1156-63. PubMed ID: 27043655
[TBL] [Abstract][Full Text] [Related]
18. [Diagnosis and individualized therapy of locoregional prostate carcinoma].
Wirth M; Fröhner M
Urologe A; 2000 Nov; 39(6):578-87. PubMed ID: 11138282
[No Abstract] [Full Text] [Related]
19. Prostate Cancer With Isolated Bony Metastasis: Sternal Struggle.
Corkum MT
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):492-493. PubMed ID: 28581385
[No Abstract] [Full Text] [Related]
20. Prostate-specific antigen best practice policy--part II: prostate cancer staging and post-treatment follow-up.
Carroll P; Coley C; McLeod D; Schellhammer P; Sweat G; Wasson J; Zietman A; Thompson I
Urology; 2001 Feb; 57(2):225-9. PubMed ID: 11182325
[No Abstract] [Full Text] [Related]
[Next] [New Search]
